Finance

Lists
7UX:FRA
Spago Nanomedical AB (publ)
€0.0090
+2.27%
(+0.00020) 1D
Sep 4, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 7UX...
Open
€0.00
High
€0.01
Low
€0.00
Mkt. cap
93.08M
Volume
0.00
52-wk high
€0.02
52-wk low
€0.00
No. of employees
6
Open
€0.00
High
€0.01
Low
€0.00
Mkt. cap
93.08M
Volume
0.00
52-wk high
€0.02
52-wk low
€0.00
No. of employees
6
About Spago Nanomedical AB (publ)
CEO-
Employees6
Founded1999
Headquarters-
SectorBiotechnology
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.25M
481.00K
1.07M
1.01M
Cost of goods sold
3.09M
2.51M
3.32M
3.32M
Cost of revenue
3.09M
2.51M
3.32M
3.32M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.31M
4.37M
4.60M
5.05M
Operating expense
4.48M
3.62M
4.65M
5.10M
Total operating expenses
7.57M
6.12M
7.97M
8.42M
Operating income
-6.32M
-5.64M
-6.90M
-7.41M
Other non operating income
-1.00K
-
-1.00K
-1.00K
EBT including unusual items
-6.26M
-5.89M
-6.80M
-7.33M
EBT excluding unusual items
-6.26M
-5.74M
-6.80M
-7.33M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
145.00K
-776.00K
25.00K
34.00K
Net income
-6.26M
-5.89M
-6.80M
-7.33M
Net profit margin
-501.20%
-1,224.53%
-635.33%
-728.73%
Earnings per share
-
-
-
-
Interest and investment income
53.00K
219.00K
99.00K
81.00K
Interest expense
-
-
-
-
Net interest expenses
53.00K
219.00K
99.00K
81.00K
Depreciation and amortization charges
21.00K
21.00K
18.00K
16.00K
EBITDA
-6.30M
-5.62M
-6.88M
-7.40M
Gain or loss from assets sale
-
-551.00K
-
-
AI content may include mistakes. Learn more
Google apps